In a landmark move for public health and vaccine accessibility, the Indian Council of Medical Research (ICMR) has granted licensing rights for its malaria vaccine, AdFalciVax, to five pharmaceutical companies. This decision is expected to accelerate the production and distribution of the vaccine across India, targeting regions with high malaria prevalence. The move underscores India’s commitment to combating malaria through indigenous innovation and public-private collaboration.